Small extracellular vesicles derived from hypoxic preconditioned dental pulp stem cells ameliorate inflammatory osteolysis by modulating macrophage polarization and osteoclastogenesis.
Small extracellular vesicles derived from hypoxic preconditioned dental pulp stem cells ameliorate inflammatory osteolysis by modulating macrophage polarization and osteoclastogenesis.
复制标题
来自缺氧预条件牙髓干细胞的小细胞外囊泡通过调节巨噬细胞极化和破骨细胞生成来改善炎症性骨溶解。
DOI:
10.1016/j.bioactmat.2022.10.001
复制
发表时间:
2023-04
影响因子:
18.9
通讯作者:
Wei, Xi
中科院分区:
文献类型:
--
作者:
Tian, Jun;Chen, Weiyang;Xiong, Yuhua;Li, Qianer;Kong, Siyi;Li, Mengjie;Pang, Chunfeng;Qiu, Yu;Xu, Zhezhen;Gong, Qimei;Wei, Xi
Extensive macrophage inflammatory responses and osteoclast formation are predominant during inflammatory or infective osteolysis. Mesenchymal stem cell (MSC)-derived small extracellular vesicles (MSC-sEV) have been shown to exert therapeutic effects on bone defects. However, cultured MSCs are typically exposed to normoxia (21% O2) in vitro, which differs largely from the oxygen concentration in vivo under hypoxic conditions. It is largely unknown whether sEV derived from dental pulp stem cells (DPSCs) cultured under hypoxic conditions (Hypo-sEV) exert better therapeutic effects on lipopolysaccharide (LPS)-induced inflammatory osteolysis than those cultured under normoxic conditions (Nor-sEV) by simultaneously inhibiting the macrophage inflammatory response and osteoclastogenesis. In this study, we show that hypoxia significantly induces the release of sEV from DPSCs. Moreover, Hypo-sEV exhibit significantly improved efficacy in promoting M2 macrophage polarization and suppressing osteoclast formation to alleviate LPS-induced inflammatory calvarial bone loss compared with Nor-sEV. Mechanistically, hypoxia preconditioning markedly alters the miRNA profiles of DPSC-sEV. MiR-210-3p is enriched in Hypo-sEV, and can simultaneously induce M2 macrophage generation and inhibit osteoclastogenesis by targeting NF-κB1 p105, which attenuates osteolysis. Our study suggests a promising potential for hypoxia-induced DPSC-sEV to treat inflammatory or infective osteolysis and identifies a novel role of miR-210-3p in concurrently hindering osteoclastogenesis and macrophage inflammatory response by inhibiting NF-kB1 expression. Hypoxia promotes the release of sEV from DPSCs. Hypoxia-induced DPSC-sEV (Hypo-sEV) show increased potential to inhibit inflammatory osteolysis. The miR-210-3p enriched in Hypo-sEV contributes to therapeutic effects of Hypo-sEV. MiR-210-3p concurrently induces M2 macrophage generation and inhibits osteoclastogenesis by targeting NF-κB1. Hypoxia-induced DPSC-sEV represent a promising therapy for inflammatory osteolysis.
登录
查看更多内容
影响因子:
16
作者:
Lee KS;Lee J;Kim HK;Yeom SH;Woo CH;Jung YJ;Yun YE;Park SY;Han J;Kim E;Sul JH;Jung JM;Park JH;Choi JS;Cho YW;Jo DG
通讯作者:
Jo DG
DOI:
10.4161/cc.9.6.11006
发表时间:
2010-03-15
期刊:
Cell cycle (Georgetown, Tex.)
影响因子:
--
作者:
Chan SY;Loscalzo J
通讯作者:
Loscalzo J
影响因子:
8.1
作者:
Imanishi Y;Hata M;Matsukawa R;Aoyagi A;Omi M;Mizutani M;Naruse K;Ozawa S;Honda M;Matsubara T;Takebe J
通讯作者:
Takebe J
影响因子:
9.2
作者:
Kwak, Sung Chul;Baek, Jong Min;Kim, Ju-Young
通讯作者:
Kim, Ju-Young
影响因子:
4.4
作者:
Ji, Lujun;Bao, Liuliu;Feng, Xingmei
通讯作者:
Feng, Xingmei